Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noel W Clarke

Showing results (1-10 of 169) with videos related to

Pageof 17
Sort By:
European Urology|December 21, 2010
Is population screening for prostate cancer good or bad?Noel W Clarke
European Urology|June 27, 2006
Management of the spectrum of hormone refractory prostate cancerNoel W Clarke
European Urology|August 22, 2012
Coming up for air: follow-up and risk stratification after negative prostate cancer screeningNoel W Clarke
European Urology|November 13, 2007
Editorial comment on: noninvasive detection of testicular carcinoma in situ in semen using OCT3/4Noel W Clarke
European Urology|October 21, 2022
Following the Narrow PathNoel W Clarke
Nature Reviews. Urology|July 7, 2009
Clinical guidelines: should 5 alpha-reductase inhibitors be used for prostate disease?Noel W Clarke
European Urology|October 12, 2010
Integrating surgery with targeted therapies for renal cell carcinoma: maximizing benefits, minimizing riskNoel W Clarke
European Urology|August 15, 2008
Bisphosphonates in hormone-refractory prostate cancer: do we have a toxicity problem?Noel W Clarke
European Urology|June 6, 2017
Re: Nicola Fossati, Peter-Paul M. Willemse, Thomas Van den Broeck, et al. The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review. Eur Urol 2017;72:84-109: Lymphadenectomy and Radical Prostatectomy: Science or Pseudoscience?Noel W Clarke
European Urology|September 26, 2006
The origin of the bone scan as a tumour marker in prostate cancerNoel W Clarke
Pageof 17

Showing results (1-10 of 169) with videos related to

Sort By:
Pageof 17
European Urology|December 21, 2010
Is population screening for prostate cancer good or bad?Noel W Clarke
European Urology|June 27, 2006
Management of the spectrum of hormone refractory prostate cancerNoel W Clarke
European Urology|August 22, 2012
Coming up for air: follow-up and risk stratification after negative prostate cancer screeningNoel W Clarke
European Urology|November 13, 2007
Editorial comment on: noninvasive detection of testicular carcinoma in situ in semen using OCT3/4Noel W Clarke
European Urology|October 21, 2022
Following the Narrow PathNoel W Clarke
Nature Reviews. Urology|July 7, 2009
Clinical guidelines: should 5 alpha-reductase inhibitors be used for prostate disease?Noel W Clarke
European Urology|October 12, 2010
Integrating surgery with targeted therapies for renal cell carcinoma: maximizing benefits, minimizing riskNoel W Clarke
European Urology|August 15, 2008
Bisphosphonates in hormone-refractory prostate cancer: do we have a toxicity problem?Noel W Clarke
European Urology|June 6, 2017
Re: Nicola Fossati, Peter-Paul M. Willemse, Thomas Van den Broeck, et al. The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review. Eur Urol 2017;72:84-109: Lymphadenectomy and Radical Prostatectomy: Science or Pseudoscience?Noel W Clarke
European Urology|September 26, 2006
The origin of the bone scan as a tumour marker in prostate cancerNoel W Clarke
Pageof 17